Meeting
2016 Gastrointestinal Cancers Symposium
Non-invasive monitoring of patient-derived orthotopic xenograft: An optimal system for rapid in vivo testing.
Authors
Mayrim V. Rios Perez
The University of Texas MD Anderson Cancer Center, Houston, TX
Mayrim V. Rios Perez , Michael Pratt , Ya'an Kang , Jason B. Fleming
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 235)
DOI
10.1200/jco.2016.34.4_suppl.235
Abstract #
235
Poster Bd #
C1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Contribution of neoadjuvant chemotherapy and radiation therapy (intensity-modulated radiation therapy with concurrent chemotherapy versus stereotactic body radiation therapy alone) on tumor volume regression in patients with borderline resectable or locally advanced pancreatic ductal adenocarcinoma: A single institution experience.
First Author: Jacob K. Jamison
Poster
2019 Gastrointestinal Cancers Symposium
CMS-PDX: A 20-gene genomic panel to predict consensus molecular subtypes in patient-derived xenografts (PDX) of colorectal cancer.
First Author: Steven Allen Buechler
Poster
2018 ASCO Annual Meeting
Doxorubicin (D), gemcitabine (G), ifosfamide (I) and the EZH2 inhibitor EPZ-011989 in epithelioid sarcoma (ES): A comparison of different regimens in a patient-derived xenograft (PDX) model.
First Author: Nadia Zaffaroni
Poster
2024 ASCO Breakthrough
A potent and selective pan-RAS inhibitor, ADT-1004, targeting complex KRAS mutations for pancreatic cancer.
First Author: Gary Piazza